M. Tanihara et al., "A Synthetic Peptide Corresponding to 86-93 of the Type I IL-1 Receptor Binds Human Recombinant IL-1 (.alpha. and .beta.) and Inhibits IL-1 Actions in Vitro and in Vivo", Biochem. Biophys. Res. Comm., vol. 188, No. 2, Oct. 30, 1992, pp. 912-920. |
S.K. Dower et al., "Retention of Ligand Binding Activity By the Extracellular Domain of the IL-1 Receptor", J. Immunology, vol. 142, No. 12 Jun. 15, 1989, pp. 4314-4320. |
C.R. Maliszewski et al., "Cytokine Receptors and B Cell Functions: I. Recombinant Soluble Receptors Specifically Inhibit IL-1-and IL-4-Induced B Cell Activities in Vitro," Journal of Immunology, vol. 144, No. 8, Apr. 15, 1990, pp. 3028-3033. |
P. Seckinger et al., "Natural and Recombinant Human IL-1 Receptor Antagonists Block the Effects of IL-1 on Bone Resorption and Prostaglandin Production", Journal of Immunology, vol. 145, No. 12, Dec. 15, 1990, pp. 4181-4184. |
M. Gowen et al., Nature, vol. 306 (1983) pp. 378-381. |
J. Pfeilschifter et al., J. of Bone and Mineral Res., vol. 4, No. 1 (1989) pp. 113-118. |
B.M. Thomson et al., J. Exp. Med. (1986) pp. 104-112. |
Gershenwald et al PNAS 87, 1990, pp. 966-970. |
Fanslow et al Science 248, 1990, pp. 739-742. |
Cominelli et al J. Clin. Invest 86, 1990, pp. 972-980. |